A detailed history of Meadow Brook Investment Advisors LLC transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Meadow Brook Investment Advisors LLC holds 1,500 shares of SNDX stock, worth $24,135. This represents 0.03% of its overall portfolio holdings.

Number of Shares
1,500
Previous 1,700 11.76%
Holding current value
$24,135
Previous $34.9 Million 17.27%
% of portfolio
0.03%
Previous 0.03%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$17.93 - $24.81 $3,586 - $4,962
-200 Reduced 11.76%
1,500 $28.9 Million
Q4 2023

Feb 06, 2024

BUY
$11.39 - $21.67 $19,363 - $36,839
1,700 New
1,700 $36.7 Million

Others Institutions Holding SNDX

About Syndax Pharmaceuticals Inc


  • Ticker SNDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,565,200
  • Market Cap $910M
  • Description
  • Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...
More about SNDX
Track This Portfolio

Track Meadow Brook Investment Advisors LLC Portfolio

Follow Meadow Brook Investment Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meadow Brook Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Meadow Brook Investment Advisors LLC with notifications on news.